汇宇制药：预计2025年度净利润同比下降108.91%至107.38%

Core Viewpoint - The company, Huyou Pharmaceutical, anticipates a significant decline in net profit for the fiscal year 2025, projecting a loss between 29 million to 24 million yuan, which represents a year-over-year decrease of 108.91% to 107.38% [2] Financial Performance - The expected net profit attributable to the parent company for 2025 is projected to be between -29 million yuan and -24 million yuan [2] - The anticipated operating revenue for 2025 is estimated to be between 960 million yuan and 1.09 billion yuan [2]